Abstract
Introduction Smart insufflation (SI) techniques relying on valve and membrane-free insufflation are increasing in usage. Although considerable literature exists demonstrating the benefits of SI on procedural ease and patient outcomes, there remains a paucity describing the financial impact of these devices. The purpose of this study was to determine the financial and efficiency impact of these devices on the operating room (OR) and inpatient wards of a hospital.
Methods A discrete event simulation model representing a typical mid-sized North American hospital comparing SI to TI was generated. The National Surgical Quality Improvement (NSQIP) database from 2015 to 2019 was used to populate the model with data supplemented from literature. Outcomes included length of stay (LOS), duration of surgery (DOS), annual procedure volume, profit, return on investment (ROI), and gross profit margin (GPM).
Results The operational parameters demonstrating favorability of SI to TI were DOS and LOS. DOS savings were 10-32 minutes/case while LOS savings were 0-3 days/case. Implementation of an SI led to an increase in annual throughput of 148 cases (12%). LOS decreased by 189 days (19%). This resulted in an increase in net profit of $104,675 per annum. The ROI of SI over TI device was >1000%.
Conclusion Despite the initial financial investment being greater, the implementation of SI offsets these expenses and yields significant financial benefits. Our study demonstrates the financial benefits of SI over TI and illustrates how granular operational and financial analysis of technologies are essential to aid in sound healthcare procurement decision making.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NA
Funding Statement
Research funding to conduct this study was provided by a research innovation grant provided by ConMed Corporation (#IRB 22-0113-C). These funds were used for student researcher remuneration, software, and manuscript dissemination. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Mount Sinai Hospital Research Ethics Board Committee 700 University Avenue, 8th fl., Suite 8-600 Toronto, Ontario, Canada, M5G 1Z5 t: (416) 586-4875 f: (416) 586-4715 www.mtsinai.on.ca
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Co-authors: Aazad Abbas, HBSc, MD, Role: Co-investigator. Ideation. Data analysis. Manuscript preparation., Email: aazad.abbas{at}mail.utoronto.ca, 1 King’s College Circle, Toronto, ON, M5S 1A8, Canada, Imran Saleh, BMATH, MSc., Role: Co-investigator. Ideation. Data analysis. Manuscript preparation.. Email: imran.saleh{at}mail.utoronto.ca, 164 College St, Toronto, ON M5S 3E2, Canada, Graeme Hoit, MD, PhD (c), Role: Co-investigator. Ideation. Manuscript preparation., Email: graeme.hoit{at}mail.utoronto.ca, 149 College Street Room 508-A, Toronto, ON, M5T 1P5, Canada, Sam Park, MD, MASc, FRCSC, Role: Co-investigator. Ideation. Manuscript preparation., Email: sam.park{at}wchospital.ca, 76 Grenville St, Toronto, ON, M5S 1B2, Canada, Cari Whyne, PhD, FIOR, Role: Co-investigator. Ideation. Manuscript preparation., Email: cari.whyne{at}sunnybrook.ca, Sunnybrook Health Sciences Centre, 2075 Bayview Ave., Room S 620, Toronto, ON, M4N 3M5, Phone: 1-416-480-6100, ext. 5056, Jay Toor, MD, MBA, FRCSC, Role: Co-investigator. Ideation. Manuscript preparation., Email: jay.toor{at}mail.utoronto.ca, 149 College Street Room 508-A, Toronto, ON, M5T 1P5, Canada
Financial disclosure: Research funding to conduct this study was provided by a research innovation grant provided by ConMed Corporation (#IRB 22-0113-C). These funds were used for student researcher remuneration, software, and manuscript dissemination. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Data Availability
Data used in this study can be found in this manuscript as well as the American Academy of Surgery (ACS) National Surgical Quality Improvement Program (NSQIP) database.
https://www.facs.org/quality-programs/data-and-registries/acs-nsqip/
